SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SEC FILE No.: 0-15260
CUSIP No.
FORM 12b-25
Notification of Late Filing
(Check One):
[X] Form 10-KSB [ ] Form 11-K [ ] Form 20-F
[ ] Form 10-QSB [ ] Form N-SAR
For Period ended:
[x] Transition Report on Form 10-K
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 10-K
For the Transition Period Ended:
--------------------------------------------------------------------------------
Nothing in this Form shall be construed to imply that the Commission has
verified any information contained herein.
--------------------------------------------------------------------------------
If the Notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
--------------------------------------------------------------------------------
Part I-Registrant Information
--------------------------------------------------------------------------------
BRL Holdings, Inc.
--------------------------------------------------------------------------------
Full Name of Registrant:
N/A
--------------------------------------------------------------------------------
Former Name if Applicable:
340 Granite Street, Suite 200
--------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
Manchester, NH 03102-4004
--------------------------------------------------------------------------------
City, State and Zip Code
PART II - RULES 12b-25 (b) AND (c)
--------------------------------------------------------------------------------
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed (Check box if appropriate)
[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[ ] (b) The subject quarterly report on Form 10-Q will be filed on or
before the fifth calendar day following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule
12(b)-25(c) has been attached if applicable.
--------------------------------------------------------------------------------
PART III - NARRATIVE
--------------------------------------------------------------------------------
State below in reasonable detail the reasons why the Form 10-K, 11-K, 20-K, 10-Q
or N-SAR or a portion thereof could not be filed within the prescribed time
period.
The Company has changed its audit firm and additional time is required for them
to complete the audit and to insure that our reports are in compliance with the
regulations of the Securities and Exchange Commission.
--------------------------------------------------------------------------------
Part IV-Other Information
--------------------------------------------------------------------------------
Name and telephone number of person to contact in regard to this notification.
R. Bruce Reeves (603) 641-8443
--------------------------------------------------------------------------------
(Name) ` (Area code) Telephone Number
Have all other periodic reports required under section 30 of the Securities
Exchange Act of 1934 or section 30 of Investment Company Act of 1940 during the
proceeding 12 months or for such shorter period that the registrant was required
to file such report(s) been filed? If the answer is no, identify report (s).
[X] Yes [ ] No
Is it anticipated that any significant change in results of operations from the
corresponding period for the last fiscal year will be reflected by the earnings
statements to be included in the subject report or portion thereof?
[x] Yes [ ] No
If so: attach an explanation of the anticipated change both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
The Company's statement of operations will show a reduced profit over last year
primarily as a result of $135,000 of administrative expense in the form of
shares to directors, officers and consultants in lieu of direct payment.
Additionally, a charge off is reported in this fiscal year of $3,662,145 for the
recognized loss for decline in value of investment. Without these two items, the
net loss for fiscal year ended June 30, 2001 will be $27,065 compared with a net
income of $3,261 for fiscal year ended June 30, 2000.
<Page>
Biorelease Corp has caused this notification to be signed on its behalf by the
undersigned thereunto duly authorized.
Date September 27, 2001 By /s/ R. Bruce Reeves
----------------------- ------------------------------------
R. Bruce Reeves, President
Instruction: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
----------------------------------ATTENTION-------------------------------------
INTENTIONAL MISTATEMENTS OR OMISSIONS OF FACT CONSTITUTE FEDRAL CRIMINAL
VIOLATIONS (SEE 18 U. S. C. 1001).
--------------------------------------------------------------------------------